Your browser doesn't support javascript.
loading
Clinical Characteristics of Patients With IgG4-Related Disease Complicated by Hypocomplementemia.
Fujita, Yuya; Fukui, Shoichi; Umeda, Masataka; Tsuji, Sosuke; Iwamoto, Naoki; Nakashima, Yoshikazu; Horai, Yoshiro; Suzuki, Takahisa; Okada, Akitomo; Aramaki, Toshiyuki; Ueki, Yukitaka; Mizokami, Akinari; Origuchi, Tomoki; Watanabe, Hiroshi; Migita, Kiyoshi; Kawakami, Atsushi.
Affiliation
  • Fujita Y; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Fukui S; Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Umeda M; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Tsuji S; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Iwamoto N; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Nakashima Y; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Horai Y; Department of Internal Medicine, Sasebo City General Hospital, Nagasaki, Japan.
  • Suzuki T; Department of General Internal Medicine and Rheumatology, Clinical Research Center, National Hospital Organization (NHO) Nagasaki Medical Center, Nagasaki, Japan.
  • Okada A; Department of Rheumatology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.
  • Aramaki T; Department of Rheumatology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.
  • Ueki Y; Rheumatic Disease Center, Sasebo Chuo Hospital, Nagasaki, Japan.
  • Mizokami A; Rheumatic Disease Center, Sasebo Chuo Hospital, Nagasaki, Japan.
  • Origuchi T; Department of Rheumatology, Japan Community Healthcare Organization, Isahaya General Hospital, Nagasaki, Japan.
  • Watanabe H; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Migita K; Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
  • Kawakami A; Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Front Immunol ; 13: 828122, 2022.
Article in En | MEDLINE | ID: mdl-35296071
ABSTRACT

Background:

A proportion of patients with immunogloblin G (IgG) 4-related disease (IgG4-RD) have hypocomplementemia. We aimed to identify characteristics of such patients.

Methods:

We analyzed the demographic and clinical data and complement levels of 85 patients with IgG4-RD. We defined hypocomplementemia as serum C3 and/or C4 levels below the lower limit of normal at diagnosis. We also compared the characteristics of patients with and without IgG4-RD.

Results:

Thirty-two (38%) patients had hypocomplementemia at diagnosis. Patients with hypocomplementemia had more lymph node (p < 0.01), lung (p < 0.01), and kidney (p = 0.02) involvement and a higher IgG4-RD responder index than those without (p = 0.05). Additionally, patients with hypocomplementemia had significantly higher IgG (p < 0.01), IgG4 (p < 0.01), and soluble interleukin 2-receptor (sIL-2R) (p < 0.01) levels and total IgG minus IgG4 (p < 0.01). C3 and C4 levels negatively correlated with IgG, IgG4, and sIL-2R levels, total IgG minus IgG4, and number of IgG4-RD responder index a measure of the disease activity in IgG4-RD. Patients with hypocomplementemia at diagnosis had a significantly higher frequency of relapse (p = 0.024), as determined using the log-rank test. A multivariate logistic regression analysis showed the presence of hypocomplementemia was independently associated with relapse (OR, 6.842; 95% confidence interval [95%CI], 1.684-27.79; p = 0.007).

Conclusions:

Patients with IgG4-RD with hypocomplementemia have a more active clinical phenotype, suggesting contributions of the complement system in the pathophysiology of IgG4-RD.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G4-Related Disease / Hematologic Diseases / Immune System Diseases Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Japón

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin G4-Related Disease / Hematologic Diseases / Immune System Diseases Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Japón